<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d2 20140930//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutr Metab (Lond)</journal-id><journal-id journal-id-type="iso-abbrev">Nutr Metab (Lond)</journal-id><journal-title-group><journal-title>Nutrition &amp; Metabolism</journal-title></journal-title-group><issn pub-type="epub">1743-7075</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4465466</article-id><article-id pub-id-type="publisher-id">20</article-id><article-id pub-id-type="doi">10.1186/s12986-015-0020-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Ammonia-lowering activities and <z:uniprot sup="inside" fb="0" ids="A5UK38">carbamoyl phosphate synthetase</z:uniprot> 1 (<z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot>) induction mechanism of a natural flavonoid </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Nohara</surname><given-names>Kazunari</given-names></name><address><email>Kazunari.Nohara@uth.tmc.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Shin</surname><given-names>Youngmin</given-names></name><address><email>shinman0118@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Noheon</given-names></name><address><email>Noheon.Park@UTSouthwestern.edu</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Jeong</surname><given-names>Kwon</given-names></name><address><email>Kwon.Jeong@uth.tmc.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Baokun</given-names></name><address><email>Baokun.He@uth.tmc.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Koike</surname><given-names>Nobuya</given-names></name><address><email>nkoike@koto.kpu-m.ac.jp</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Yoo</surname><given-names>Seung-Hee</given-names></name><address><email>Seung-Hee.Yoo@uth.tmc.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Chen</surname><given-names>Zheng</given-names></name><address><phone>713-500-6284</phone><email>zheng.chen.1@uth.tmc.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><label/>Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 6.200, Houston, TX 77030 USA </aff><aff id="Aff2"><label/>Department of Neuroscience, The University of Texas Southwestern Medical Center, Dallas, TX 75390 USA </aff><aff id="Aff3"><label/>Department of Physiology and Systems Bioscience, Kyoto Prefectural University of Medicine, Kyoto, 602-8566 Japan </aff></contrib-group><pub-date pub-type="epub"><day>9</day><month>6</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>9</day><month>6</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>12</volume><elocation-id>23</elocation-id><history><date date-type="received"><day>4</day><month>3</month><year>2015</year></date><date date-type="accepted"><day>4</day><month>6</month><year>2015</year></date></history><permissions><copyright-statement>© Nohara et al. 2015</copyright-statement><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title><text><SENT sid="1" pm="."><plain>Objective </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="2" pm="."><plain>Ammonia detoxification is essential for physiological well-being, and the urea cycle in liver plays a predominant role in ammonia disposal. </plain></SENT>
<SENT sid="3" pm="."><plain>Nobiletin (NOB), a natural dietary flavonoid, is known to exhibit various physiological efficacies. </plain></SENT>
<SENT sid="4" pm="."><plain>In the current study, we investigated a potential role of NOB in ammonia control and the underlying cellular mechanism. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="5" pm="."><plain>Materials/methods </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="6" pm="."><plain>C57BL/6 mice were fed with regular chow (RC), high-fat (HFD) or high-protein diet (<z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot>) and treated with either vehicle or NOB. </plain></SENT>
<SENT sid="7" pm="."><plain>Serum and/or urine levels of ammonia and urea were measured. </plain></SENT>
<SENT sid="8" pm="."><plain>Liver expression of genes encoding urea cycle enzymes and <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> transcription factors was determined over the circadian cycle. </plain></SENT>
<SENT sid="9" pm="."><plain><z:uniprot sup="inside" fb="2" ids="Q01158,P13129,Q26304,Q27757,P08659">Luciferase</z:uniprot> reporter assays were carried out to investigate function of CCAAT consensus elements on the <z:uniprot sup="inside" fb="0" ids="A5UK38">carbamoyl phosphate synthetase</z:uniprot> (<z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot>) gene promoter. </plain></SENT>
<SENT sid="10" pm="."><plain>A circadian clock-deficient mouse mutant, ClockΔ19/Δ19, was utilized to examine a requisite role of the circadian clock in mediating NOB induction of <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot>. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="11" pm="."><plain>Results </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="12" pm="."><plain>NOB was able to lower serum ammonia levels in mice fed with RC, HFD or <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot>. </plain></SENT>
<SENT sid="13" pm="."><plain>Compared with RC, HFD repressed the mRNA and protein expression of <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot>, encoding the rate-limiting enzyme of the urea cycle. </plain></SENT>
<SENT sid="14" pm="."><plain>Interestingly, NOB rescued <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> protein levels under the HFD condition via induction of the transcription factors <z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPα</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="O02755,Q05826,P17676,P28033,P21272">C/EBPβ</z:uniprot>. </plain></SENT>
<SENT sid="15" pm="."><plain>Expression of other urea cycle genes was also decreased by HFD relative to RC and again restored by NOB to varying degrees, which, in conjunction with <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> promoter reporter analysis, suggested a <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot>-dependent mechanism for the co-induction of urea cycle genes by NOB. </plain></SENT>
<SENT sid="16" pm="."><plain>In comparison, <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot> markedly increased <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> levels relative to RC, yet NOB did not further enrich <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> to a significant extent. </plain></SENT>
<SENT sid="17" pm="."><plain>Using the circadian mouse mutant ClockΔ19/Δ19, we also showed that a functional circadian clock, known to modulate <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> expression, was required for NOB induction of <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> under the HFD condition. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="18" pm="."><plain>Conclusion </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="19" pm="."><plain>NOB, a dietary flavonoid, exhibits a broad activity in ammonia control across varying diets, and regulates urea cycle function via <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot>-and clock-dependent regulatory mechanisms. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="20" pm="."><plain>Electronic supplementary material </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="21" pm="."><plain>The online version of this article (doi:10.1186/s12986-015-0020-7) contains supplementary material, which is available to authorized users. </plain></SENT>
</text></SecTag></p></sec></abstract><SecTag type="KEYWORD"><kwd-group xml:lang="en"><title>Keywords</title><kwd>Ammonia</kwd><kwd>Urea cycle</kwd><kwd>Circadian clock</kwd><kwd>Diet</kwd><kwd>Flavonoid</kwd><kwd>C/EBP</kwd></kwd-group></SecTag><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><SecTag type="INTRO"><sec id="Sec1" sec-type="intro"><title><text><SENT sid="22" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="23" pm="."><plain>Ammonia detoxification is an essential bodily function required for nitrogen homeostasis and physiological well-being [1–3]. </plain></SENT>
<SENT sid="24" pm="."><plain>Ammonia molecules are produced mainly through catabolism of amino acid and other nitrogenous metabolites in tissues, and also via amino acid deamination and urea salvage by gut bacteria [1, 4]. </plain></SENT>
<SENT sid="25" pm="."><plain>Whereas a small portion of ammonia is removed via direct renal excretion, the urea cycle in the liver plays a predominant role in ammonia disposal, converting ammonia to the relatively harmless urea for excretion [5, 6]. </plain></SENT>
<SENT sid="26" pm="."><plain>The urea cycle consists of five enzymatic reactions sequentially taking place in the mitochondrial matrix and the cytoplasm of periportal hepatocytes [7, 8]. </plain></SENT>
<SENT sid="27" pm="."><plain><z:uniprot sup="inside" fb="0" ids="A5UK38">Carbamoyl phosphate synthetase</z:uniprot> 1 (<z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot>) catalyzes the first reaction wherein ammonia and bicarbonate combine to form carbamoyl phosphate, and mice deficient in <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> suffered pronounced hyperammonemia and neonatal lethality [9]. </plain></SENT>
<SENT sid="28" pm="."><plain>As a strikingly abundant protein comprising as much as 20 % of total mitochondrial <z:uniprot sup="inside" fb="0" ids="Q91B74,P31035,O18559,Q66112,P87577,Q9JAF2,P06502,P06503,O12705,Q77D96,Q9QSP2,Q8JTH1,Q6X1D6,P0C794,P0C795,Q9E785,P24615,P06943,Q9WH76,A7WNB1,A4UHQ0,A4UHQ5,C1JJY2,O89341,Q82038,P0DOE6,P0DOE7,O42049,Q08453,Q82682,Q5VKP4,Q5K2K5,Q6X1D2,Q6JAM6,Q9E7N9,P27287,P35976,P16628,Q9W850,P06942,P18611,P26034,P13844,P36356,Q6E0W8,P0C571,P19718,Q9JG20,P33482,Q9JGT5,P11206,P06157,Q9DLD5,Q9IK90,Q84131,P35947,P36355,Q01427,P24266,P06166,P07873,P27019,P27020,Q85212,P16629,P15200,Q66T63,P25223,Q0GBX7,P0DOF2,Q8B6J7,A3RM21,P25224,P08671,Q0GBY2,P16287,P22046,P41358,Q98664,Q88266,Q88428,P17748,P03426,O57299,P06446,Q9QJT7,P25182,P04888,P19692,Q5GA87,D8V072,P31620,Q4VKV5,P27663,P03519,Q8B0H2,P04876,Q8B0I2,Q8B0H7,P08325,Q5VKP0,Q2Y2M4,Q6WB99,Q5MKM5">matrix protein</z:uniprot> mass [10], <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> is also subjected to diverse molecular and cellular regulation. </plain></SENT>
<SENT sid="29" pm="."><plain>Besides the classically known allosteric activator N-acetylglutamate (<z:uniprot sup="inside" fb="117" ids="P54802,A2RRP1">NAG</z:uniprot>), <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> level and activity are also regulated by complex molecular and physiological mechanisms [7, 11–16]. </plain></SENT>
<SENT sid="30" pm="."><plain>Furthermore, coordinate induction of urea cycle components has also been reported at transcriptional and post-transcriptional levels [7, 17]. </plain></SENT>
</text></p><p><text><SENT sid="31" pm="."><plain>An emerging cellular mechanism for nitrogen homeostasis is our intrinsic biological timer, the circadian clock [18, 19]. </plain></SENT>
<SENT sid="32" pm="."><plain>In mammals, core clock genes form interlocked feedback loops, driving gene expression to regulate various metabolic pathways [20–22]. </plain></SENT>
<SENT sid="33" pm="."><plain>Several earlier studies have implicated a role of the clock in protein or nitrogen metabolism [23–25]. </plain></SENT>
<SENT sid="34" pm="."><plain>More recently, it was shown that the transcription factor <z:uniprot sup="inside" fb="0" ids="Q9EPW2">Klf15</z:uniprot> is encoded by a clock-controlled gene, and that <z:uniprot sup="inside" fb="0" ids="Q9EPW2">Klf15</z:uniprot> maintains nitrogen balance via regulation of the second urea cycle gene <z:uniprot sup="inside" fb="128" ids="P11725,P00481">Otc</z:uniprot> [19]. </plain></SENT>
<SENT sid="35" pm="."><plain>Furthermore, genomic and proteomic studies have also demonstrated circadian variation of <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> mRNA and protein expression in mouse liver, although discrepancies remain concerning mRNA oscillation and protein peaks [26–29]. </plain></SENT>
</text></p><p><text><SENT sid="36" pm="."><plain>Apart from the clock being an intrinsic regulator, diet is an external factor that profoundly influences nitrogen homeostasis and ammonia metabolism. </plain></SENT>
<SENT sid="37" pm="."><plain>Dietary management for genetic hyperammonemia, mainly including protein restriction and supplementation of urea cycle substrate, serves to attenuate ammonia generation and/or bolster ammonia disposal [3, 30–32]. </plain></SENT>
<SENT sid="38" pm="."><plain>On the other hand, dietary challenges also strongly influence ammonia metabolism and detoxification. </plain></SENT>
<SENT sid="39" pm="."><plain>For example, the ureagenic capacity of the urea cycle, while far exceeding demand under normal conditions [14], has been shown to be up-regulated in response to greater metabolic challenge [7, 33]. </plain></SENT>
<SENT sid="40" pm="."><plain>However, ammonia control under varying diet conditions is not well characterized, and little is known regarding functional dietary components for ammonia control besides metabolic substrates [30, 34]. </plain></SENT>
<SENT sid="41" pm="."><plain>Here, we report novel ammonia-lowering activities and clock-dependent mechanism for urea cycle regulation of a natural polyphenolic flavonoid, Nobiletin (NOB). </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec id="Sec2" sec-type="materials|methods"><title><text><SENT sid="42" pm="."><plain>Materials and methods </plain></SENT>
</text></title><sec id="Sec3"><title><text><SENT sid="43" pm="."><plain>Animals </plain></SENT>
</text></title><p><text><SENT sid="44" pm="."><plain>All animal husbandry and experimental procedures were carried out in accordance with approved IACUC guidelines and animal protocols by the University of Texas Health Science Center at Houston (UTHealth). </plain></SENT>
<SENT sid="45" pm="."><plain>All mice, male and on the C57BL/6 background, were group-housed with 2–4 animals/cage under 12:12 light/dark (12:12 LD) cycles or constant darkness (DD) when indicated. </plain></SENT>
<SENT sid="46" pm="."><plain>The point of light-on is considered as Zeitgeber Time (ZT) 0, whereas the onset of subjective day during DD is considered as Circadian Time (CT) 0. </plain></SENT>
<SENT sid="47" pm="."><plain>Animals were ad libitum fed with regular chow (RC; LabDiet 5001), high-fat diet (HFD; Research Diets D12492) or high-protein diet (<z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot>; Research Diets D04080301). </plain></SENT>
<SENT sid="48" pm="."><plain>Nobiletin was obtained from commercial sources including Sigma and Selleck, and administered via oral gavage (200 mg/kg in 0.5 % Sodium carboxymethyl cellulose) every other day. </plain></SENT>
</text></p></sec><sec id="Sec4"><title><text><SENT sid="49" pm="."><plain>Ammonia and urea assays </plain></SENT>
</text></title><p><text><SENT sid="50" pm="."><plain>Blood and urine samples were collected at ZT6 and ZT18. </plain></SENT>
<SENT sid="51" pm="."><plain>For determination of serum ammonia and urea concentrations, we employed assay kits (Sigma, AA0100 and MAK006, respectively) according to the manufacturer’s protocols. </plain></SENT>
</text></p></sec><sec id="Sec5"><title><text><SENT sid="52" pm="."><plain>Plasmids </plain></SENT>
</text></title><p><text><SENT sid="53" pm="."><plain>The proximal <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> enhancer [16] was cloned into pGL3 Basic (Promega) using C57BL6/J mouse genomic DNA as PCR template with pF and pR primers (Additional file 1: Table S1). </plain></SENT>
<SENT sid="54" pm="."><plain>Site-directed PCR mutagenesis was performed to introduce mutations on the <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> binding site using P-C/EBPmutF and P-C/EBPmutR primers (Additional file 1: Table S1). </plain></SENT>
<SENT sid="55" pm="."><plain>Likewise, the distal enhancer [35] was cloned into pGL3 Basic using dF and dR primers. </plain></SENT>
<SENT sid="56" pm="."><plain>Three <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> binding sites in the distal enhancer region were incorporated by DNA synthesis (GeneScript). </plain></SENT>
<SENT sid="57" pm="."><plain><z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPα</z:uniprot> expression vector was purchased from Addgene (ID12550). </plain></SENT>
</text></p></sec><sec id="Sec6"><title><text><SENT sid="58" pm="."><plain><z:uniprot sup="inside" fb="2" ids="Q01158,P13129,Q26304,Q27757,P08659">Luciferase</z:uniprot> reporter assays </plain></SENT>
</text></title><p><text><SENT sid="59" pm="."><plain>For the luminescence assay, Hepa1-6 cells (ATCC, CRL-1830) were plated the day before transfection at 2 × 104 cells per well in 96-well plates. </plain></SENT>
<SENT sid="60" pm="."><plain>Cells were transfected with the indicated vectors with Renilla <z:uniprot sup="inside" fb="2" ids="Q01158,P13129,Q26304,Q27757,P08659">luciferase</z:uniprot> vector for internal control. </plain></SENT>
<SENT sid="61" pm="."><plain>Twenty four hours after transfection, media was changed to recording media as previously described [36] and treated with different concentrations of Nobiletin. </plain></SENT>
<SENT sid="62" pm="."><plain>Sealed cultures were placed in an EnVision microplate reader (Perkin Elmer) and bioluminescence from the tissue was recorded. </plain></SENT>
</text></p></sec><sec id="Sec7"><title><text><SENT sid="63" pm="."><plain>Real-time qPCR and Western blot analyses </plain></SENT>
</text></title><p><text><SENT sid="64" pm="."><plain>Total RNAs purified by using Trizol were used for cDNA synthesis and real-time qPCR was performed with an Agilent MaxPro3000 Thermocycler using SyBR green reaction mix (GenDEPOT). </plain></SENT>
<SENT sid="65" pm="."><plain>The qPCR primers used are listed in Additional file 1: Table S2. </plain></SENT>
</text></p><p><text><SENT sid="66" pm="."><plain>Tissue collection and Western blotting was performed as described previously [37, 38]. </plain></SENT>
<SENT sid="67" pm="."><plain>Briefly, liver tissue samples were dissected from the same lobular regions in different animals to ensure experimental consistency. </plain></SENT>
<SENT sid="68" pm="."><plain>The samples were immediately frozen in liquid nitrogen and stored at −80 °C prior to use. </plain></SENT>
<SENT sid="69" pm="."><plain>The harvested liver tissues were homogenized in extraction buffer containing 0.1 % TritonX-100. </plain></SENT>
<SENT sid="70" pm="."><plain>Protein samples were separated by 12 or 6 % SDS-polyacrylamide gel then transferred to a nitrocellulose membrane. </plain></SENT>
<SENT sid="71" pm="."><plain>Anti-<z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> (Abcam), anti-<z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPα</z:uniprot> (Cell Signaling), anti-<z:uniprot sup="inside" fb="0" ids="O02755,Q05826,P17676,P28033,P21272">C/EBPβ</z:uniprot> (Abcam) antibodies were used. </plain></SENT>
<SENT sid="72" pm="."><plain>Quantitation of Western blot results was carried out by using ImageJ software (NIH). </plain></SENT>
</text></p></sec><sec id="Sec8"><title><text><SENT sid="73" pm="."><plain>Immunohistochemistry </plain></SENT>
</text></title><p><text><SENT sid="74" pm="."><plain>Liver tissues (right lateral lobe) were collected at the indicated times and immediately fixed in 10 % buffered formalin. </plain></SENT>
<SENT sid="75" pm="."><plain>For immunohistochemistry, 20-μm sections were collected using a VibroSlice microtome (World Precision Instruments) and processed free floating. </plain></SENT>
<SENT sid="76" pm="."><plain>Sections were incubated with rabbit anti-<z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> (1:10,000; Abcam), followed by Alexa Fluor 546 rabbit secondary antibody (1:1000; Invitrogen). </plain></SENT>
<SENT sid="77" pm="."><plain>After 30 min of DAPI staining (5 μM), Vectashield mounting media (Vector Labs) was used to mount the liver slices. </plain></SENT>
<SENT sid="78" pm="."><plain>Section images were acquired and analyzed by using a Nikon A1R confocal microscope. </plain></SENT>
</text></p></sec><sec id="Sec9"><title><text><SENT sid="79" pm="."><plain>SDS-PAGE and mass spectrometry </plain></SENT>
</text></title><p><text><SENT sid="80" pm="."><plain>Liver extracts were separated on SDS-PAGE gels and minimally stained with Coomassie blue. </plain></SENT>
<SENT sid="81" pm="."><plain>The MW 164KD band was excised and digested with <z:uniprot sup="inside" fb="60" ids="Q59149,P23916,P19799,P70059,P83348,P81071,P35049,P35050,O97399,P00761,P35034,P35051,P24664,P51588,P35048,P00764,P00775">trypsin</z:uniprot>. </plain></SENT>
<SENT sid="82" pm="."><plain>The sample was subjected to mass spectrometry protein ID at the <z:uniprot sup="inside" fb="11" ids="Q02223">BCM</z:uniprot> Proteome Core Facility using a Velos-Orbitrap mass spectrometer. </plain></SENT>
<SENT sid="83" pm="."><plain>Spectral data were then identified by using Proteome Discoverer Suites with Mascot (Orbitrap data) software [39]. </plain></SENT>
</text></p></sec><sec id="Sec10"><title><text><SENT sid="84" pm="."><plain>Statistical analysis </plain></SENT>
</text></title><p><text><SENT sid="85" pm="."><plain>Unless otherwise stated, results are presented as mean ± SEM. </plain></SENT>
<SENT sid="86" pm="."><plain>Data were analyzed using Student’s t-test, one-way ANOVA followed by post-hoc analysis using Dunnett’s multiple comparison tests or two-way ANOVA followed by post-hoc analysis using Bonferroni test as appropriate. </plain></SENT>
<SENT sid="87" pm="."><plain>A value of p &lt; 0.05 was considered statistically significant. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec id="Sec11" sec-type="results"><title><text><SENT sid="88" pm="."><plain>Results </plain></SENT>
</text></title><sec id="Sec12"><title><text><SENT sid="89" pm="."><plain>NOB improves ammonium detoxification </plain></SENT>
</text></title><p><text><SENT sid="90" pm="."><plain>Among a growing number of bioactive polyphenols, Nobiletin (NOB) is a citrus-derived dietary flavonoid with diverse physiological functions [40–43]. </plain></SENT>
<SENT sid="91" pm="."><plain>More recently, NOB has been shown to display a protective role against high-fat diet (HFD)-induced obesity and other metabolic dysfunctions [44–46]. </plain></SENT>
<SENT sid="92" pm="."><plain>To investigate a potential role of NOB in nitrogen homeostasis, we examined serum ammonium levels in wild-type (WT) mice under different diets. </plain></SENT>
<SENT sid="93" pm="."><plain>Under RC, NOB did not significantly affect body weight (Fig. 1a). </plain></SENT>
<SENT sid="94" pm="."><plain>Consistent with previous findings [44, 45], NOB ameliorated body weight gain under HFD (Fig. 1a). </plain></SENT>
<SENT sid="95" pm="."><plain>Importantly however, under both diets, NOB markedly reduced serum ammonium levels (Fig. 1b). </plain></SENT>
<SENT sid="96" pm="."><plain>At Zeitgeber Time (ZT) 6 corresponding to mid-day (inactive phase), NOB led to a more pronounced reduction for HFD than RC (27.5 % vs 14.4 %) (Fig. 1b, left). </plain></SENT>
<SENT sid="97" pm="."><plain>Ammonia-lowering activities of NOB were also observed at ZT18 corresponding to mid-night when mice were active (Fig. 1b, right). </plain></SENT>
<SENT sid="98" pm="."><plain>Whereas attenuated serum ammonia levels were observed in HFD.Veh than RC.Veh, likely due to lower protein content in HFD than RC (20 % vs. 29 % in calories), NOB treatment diminished the ammonia levels in both diets by similar degrees.Fig. 1Nobiletin (NOB) lowers serum ammonia levels. a Body weight change of wild-type (WT) mice fed with regular chow (RC) or high-fat diet (HFD) and treated with either vehicle (Veh) or Nobiletin (NOB) for 10 weeks (n = 11–12). ***p &lt; 0.001. b Serum ammonia levels at Zeitgeber Time (ZT) 6 and 18 in the mice described in (a). </plain></SENT>
<SENT sid="99" pm="."><plain>ZT0 corresponds to the onset of light phase. c Body weight change of WT mice fed with RC or high-protein diet (<z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot>) and treated with either Veh or NOB for 4 weeks (n = 6–7). d Serum ammonia levels at ZT6 and ZT18 in the mice described in (c). </plain></SENT>
<SENT sid="100" pm="."><plain>Data are presented as mean ± SEM. </plain></SENT>
<SENT sid="101" pm="."><plain>For panels b and d, Student’s t-test: Veh vs. NOB, **p &lt; 0.01, ***p &lt; 0.001; RC vs. HFD or <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot>, ††p &lt; 0.01 </plain></SENT>
</text></p><p><text><SENT sid="102" pm="."><plain>We next investigated effects of NOB under high-protein diet (<z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot>), corresponding to enhanced protein metabolism and ammonia flux [19]. </plain></SENT>
<SENT sid="103" pm="."><plain>NOB did not significantly affect body weight in these mice (Fig. 1c). </plain></SENT>
<SENT sid="104" pm="."><plain>At ZT6, serum ammonia levels were similar between RC and <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot>, and NOB showed a modest trend of reducing serum ammonia levels (Fig. 1d, left). </plain></SENT>
<SENT sid="105" pm="."><plain>Importantly, during the active phase at ZT18 when serum ammonia levels were significantly elevated in <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot>, NOB robustly reduced serum ammonia to RC levels (Fig. 1d, right). </plain></SENT>
<SENT sid="106" pm="."><plain>Together, these results indicated a broad role of NOB in reducing serum ammonia content at both active and inactive circadian phases under RC, HFD and <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot> conditions. </plain></SENT>
<SENT sid="107" pm="."><plain>Furthermore, NOB more strongly reduced serum ammonia levels under HFD and <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot> at ZT6 and ZT18 respectively, serving to normalize the exaggerated circadian variation between active and inactive phases in these diets compared with RC. </plain></SENT>
</text></p></sec><sec id="Sec13"><title><text><SENT sid="108" pm="."><plain>Diet-specific effects of NOB on <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> expression </plain></SENT>
</text></title><p><text><SENT sid="109" pm="."><plain><z:uniprot sup="inside" fb="0" ids="P31327,Q91293,Q8C196,P07756">Carbamoyl phosphate synthetase I</z:uniprot> (<z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot>) has been shown to accumulate in a circadian manner; however, <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> proteins are exceedingly abundant and discrepancy in circadian pattern exists [26, 27]. </plain></SENT>
<SENT sid="110" pm="."><plain>We therefore conducted Western blotting to examine <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> protein levels in mouse liver over circadian time course. </plain></SENT>
<SENT sid="111" pm="."><plain>While largely unchanged between Veh and NOB treatment under RC conditions based on 2-way ANOVA, <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> levels were significantly reduced in HFD.Veh compared with RC (Fig. 2a and Additional file 1: Figure <z:uniprot sup="inside" fb="3" ids="P28878,P02350">S1A</z:uniprot>) [47]. </plain></SENT>
<SENT sid="112" pm="."><plain>Strikingly, NOB restored <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> in HFD to RC levels (Fig. 2a). </plain></SENT>
<SENT sid="113" pm="."><plain>We also confirmed the above results using Coomassie staining followed by mass spectrometry (Additional file 1: Figure <z:uniprot sup="inside" fb="0" ids="P47835">S1B</z:uniprot> and Table S3). </plain></SENT>
<SENT sid="114" pm="."><plain>Furthermore, confocal microscopy using anti-<z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> antibody also clearly showed recovered <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> in livers from HFD.NOB mice relative to HFD.Veh (Fig. 2b and Additional file 1: Figure S1C). </plain></SENT>
<SENT sid="115" pm="."><plain>Real-time qPCR analysis further revealed strong repression of <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> messenger levels by HFD relative to RC (Fig. 2c), consistent with its effect on <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> proteins. </plain></SENT>
<SENT sid="116" pm="."><plain>Importantly, NOB restored <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> mRNA expression, mirroring the changes in <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> protein.Fig. 2NOB modulates <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> mRNA and protein expression. a Total protein extracts were prepared from liver samples collected from the four diet/treatment groups of wild-type mice at the indicated circadian time points (n = 3). </plain></SENT>
<SENT sid="117" pm="."><plain>Western blotting analysis was performed using anti-<z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> antibody. RC regular chow, HFD high-fat diet, Veh vehicle, NOB Nobiletin. </plain></SENT>
<SENT sid="118" pm="."><plain>The results shown are representative of three independent experiments. </plain></SENT>
<SENT sid="119" pm="."><plain>See Additional file 1: Figure <z:uniprot sup="inside" fb="3" ids="P28878,P02350">S1A</z:uniprot> for quantitative analysis. b Immunohistochemical staining of <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> in liver sections from mice with the indicated diet and treatment at ZT2. c Real-time RT-PCR analysis of <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> in liver samples collected as in (a). </plain></SENT>
<SENT sid="120" pm="."><plain>Data are presented as mean ± SEM (n = 3). </plain></SENT>
<SENT sid="121" pm="."><plain>Two-way ANOVA with Bonferroni post-hoc tests shows significant statistical differences between HFD.Veh and other three groups (p &lt; 0.0001). d Western blotting analysis of protein lysates of liver samples collected at ZT 6 and 18 from mice with the indicated diet and treatment (n = 3). </plain></SENT>
<SENT sid="122" pm="."><plain><z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot> indicates high-protein diet. </plain></SENT>
<SENT sid="123" pm="."><plain>The images shown to the left are representative of three independent experiments. </plain></SENT>
<SENT sid="124" pm="."><plain>Quantitation of Western blots was carried out and the results, presented as mean ± SEM, are shown in the lower panel. </plain></SENT>
<SENT sid="125" pm="."><plain>Two-way ANOVA with Bonferroni post-hoc tests, RC vs. <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot>, ***p &lt; 0.001. e Real-time qPCR analysis was carried out using total RNAs extracted from the liver samples described in (d). </plain></SENT>
<SENT sid="126" pm="."><plain>The results are presented as mean ± SEM. </plain></SENT>
<SENT sid="127" pm="."><plain>Two-way ANOVA with Bonferroni post-hoc tests, RC vs. <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot>, *p &lt; 0.05 </plain></SENT>
</text></p><p><text><SENT sid="128" pm="."><plain>We also examined effects of <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot> on <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> levels. </plain></SENT>
<SENT sid="129" pm="."><plain><z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot> enhanced the abundance of <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> by approximately 20 % (Fig. 2d), suggesting a role of <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> induction to cope with increased dietary protein intake. </plain></SENT>
<SENT sid="130" pm="."><plain><z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot> feeding exerted similar modest inducing effects on <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> mRNA compared with RC (Fig. 2e). </plain></SENT>
<SENT sid="131" pm="."><plain>NOB treatment, on the other hand, did not further increase <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> protein level under <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot> (Fig. 2d), yet seemed to alter the mRNA expression with a slight increase at ZT18 (Fig. 2e). </plain></SENT>
<SENT sid="132" pm="."><plain>These results indicated opposing effects of HFD and <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot> on <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> expression, suggesting that ammonia-lowering activities of NOB entail diet-specific <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> regulatory mechanisms. </plain></SENT>
</text></p></sec><sec id="Sec14"><title><text><SENT sid="133" pm="."><plain>NOB restored levels of <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> transcription factors repressed under HFD </plain></SENT>
</text></title><p><text><SENT sid="134" pm="."><plain>We next focused on HFD where the above results indicated NOB-mediated transcriptional induction of <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot>. </plain></SENT>
<SENT sid="135" pm="."><plain>The transcription factors <z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPα</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="O02755,Q05826,P17676,P28033,P21272">C/EBPβ</z:uniprot> are known to play important roles in energy homeostasis and urea cycle expression [7, 48, 49]. </plain></SENT>
<SENT sid="136" pm="."><plain>Consistent with previous results [50], liver expression of both <z:uniprot sup="inside" fb="0" ids="P53566">Cebp</z:uniprot> genes exhibited clear circadian oscillation in RC; somewhat surprisingly, NOB moderately elevated <z:uniprot sup="inside" fb="0" ids="P53566,P05554">Cebpa</z:uniprot> expression, yet strongly repressed <z:uniprot sup="inside" fb="0" ids="P28033,P21272">Cebpb</z:uniprot> (Fig. 3a). </plain></SENT>
<SENT sid="137" pm="."><plain>HFD significantly dampened levels and circadian amplitude (peak/trough difference) of both <z:uniprot sup="inside" fb="0" ids="P53566">Cebp</z:uniprot> mRNA expression, and interestingly also reversed their circadian phase. </plain></SENT>
<SENT sid="138" pm="."><plain>NOB treatment largely restored <z:uniprot sup="inside" fb="0" ids="P53566,P05554">Cebpa</z:uniprot> mRNA expression (ZT14) and circadian phase relative to RC (Fig. 3a).Fig. 3NOB rescued <z:uniprot sup="inside" fb="0" ids="P53566,P05554">Cebpa</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="P28033,P21272">Cebpb</z:uniprot> mRNA and protein circadian expression in the liver from HFD fed mice. a Real-time RT-PCR analysis of <z:uniprot sup="inside" fb="0" ids="P53566,P05554">Cebpa</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="P28033,P21272">Cebpb</z:uniprot> in livers collected at the indicated circadian times from mice with the indicated diet and treatment as in Fig. 2a. </plain></SENT>
<SENT sid="139" pm="."><plain>Student’s t-test: RC.Veh vs. HFD.Veh, *p &lt; 0.05; HFD.Veh vs. HFD.NOB, †p &lt; 0.05. b Western blotting was performed using total liver protein lysates with the indicated antibodies. </plain></SENT>
<SENT sid="140" pm="."><plain>The results are representative of three independent experiments. </plain></SENT>
<SENT sid="141" pm="."><plain>See Additional file 1: Figure S2 for quantitative analysis </plain></SENT>
</text></p><p><text><SENT sid="142" pm="."><plain>HFD also significantly down-regulated protein levels of <z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPα</z:uniprot> <z:uniprot sup="inside" fb="5" ids="P19899,P16580,Q8NFH3,Q27272">p42</z:uniprot>, the active form [51], across the circadian cycle (HFD.Veh vs. RC.Veh; Fig. 3b and Additional file 1: Figure S2A). </plain></SENT>
<SENT sid="143" pm="."><plain>In comparison, the amount of <z:uniprot sup="inside" fb="15" ids="P22959,P27210,P30151,P19738,P26625,P34204,P0C9Z1,P0C9Z2,P0C9Z3,P0C9Z4,P75330,P26382,O74503,Q08747">p30</z:uniprot>, the truncated form lacking the N-terminal transactivation domain, was also reduced, albeit to a lesser degree (Fig. 3b and Additional file 1: Figure S2B). </plain></SENT>
<SENT sid="144" pm="."><plain>Compared with Veh, NOB did not show significant effects on <z:uniprot sup="inside" fb="5" ids="P19899,P16580,Q8NFH3,Q27272">p42</z:uniprot>/<z:uniprot sup="inside" fb="15" ids="P22959,P27210,P30151,P19738,P26625,P34204,P0C9Z1,P0C9Z2,P0C9Z3,P0C9Z4,P75330,P26382,O74503,Q08747">p30</z:uniprot> levels in RC, yet appeared to reverse their reduction by HFD to RC levels (Fig. 3b and Additional file 1: Figure S2A). </plain></SENT>
<SENT sid="145" pm="."><plain>HFD was previously reported to increase <z:uniprot sup="inside" fb="0" ids="O02755,Q05826,P17676,P28033,P21272">C/EBPβ</z:uniprot> (<z:uniprot sup="inside" fb="0" ids="Q02HI0,P35482,K4LAH1">LAP</z:uniprot> and LIP) levels in mouse liver [52]. </plain></SENT>
<SENT sid="146" pm="."><plain>In comparison, our circadian analysis revealed a <z:uniprot sup="inside" fb="0" ids="O02755,Q05826,P17676,P28033,P21272">C/EBPβ</z:uniprot> (<z:uniprot sup="inside" fb="0" ids="Q02HI0,P35482,K4LAH1">LAP</z:uniprot>) phase shift in HFD (Fig. 3b and Additional file 1: Figure S2C). </plain></SENT>
<SENT sid="147" pm="."><plain>Whereas both RC.Veh and RC.NOB showed <z:uniprot sup="inside" fb="0" ids="P69145">peak C</z:uniprot>/<z:uniprot sup="inside" fb="0" ids="P43084,Q60490,Q15125,P42736,Q5HYK7">EBP</z:uniprot>β expression at ZT20, HFD shifted the peak to ZT14, with HFD.NOB displaying a slight increase over HFD.Veh (Fig. 3b and Additional file 1: Figure S2C). </plain></SENT>
<SENT sid="148" pm="."><plain>These results illustrated circadian- and diet-dependent expression patterns of <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBPs</z:uniprot> and a novel function of NOB in restoring <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> levels repressed by HFD. </plain></SENT>
</text></p></sec><sec id="Sec15"><title><text><SENT sid="149" pm="."><plain><z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> site mutations on the <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> promoter abolished NOB effects </plain></SENT>
</text></title><p><text><SENT sid="150" pm="."><plain>Previous studies have identified both proximal and distal <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> sites in the <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> promoter [16, 35, 53]. </plain></SENT>
<SENT sid="151" pm="."><plain>We next generated reporter constructs containing either the intact <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> promoter or mutant promoters respectively deficient in either <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> sites (Fig. 4a). </plain></SENT>
<SENT sid="152" pm="."><plain>NOB was found to dose-dependently activate reporter expression from the WT construct with an intact promoter (Fig. 4b and c). </plain></SENT>
<SENT sid="153" pm="."><plain>Distal mutations markedly repressed the reporter expression, yet seemed to at least partially retain NOB response as NOB increased mutant reporter expression relative to DMSO (Fig. 4b). </plain></SENT>
<SENT sid="154" pm="."><plain>In comparison, while not significantly affecting the baseline expression level, proximal mutations abolished NOB dose-dependent induction seen in the WT construct (Fig. 4c). </plain></SENT>
<SENT sid="155" pm="."><plain><z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPα</z:uniprot> co-transfection activated both proximal and distal WT reporter expression, but showed no effects on mutant constructs in the absence of NOB. </plain></SENT>
<SENT sid="156" pm="."><plain>These results suggested that the proximal <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> consensus site plays a major role in mediating the NOB induction of <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot>.Fig. 4C/<z:uniprot sup="inside" fb="0" ids="P43084,Q60490,Q15125,P42736,Q5HYK7">EBP</z:uniprot> binding site mutations in proximal and distal <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> enhancer regions impaired NOB-mediated reporter activation. a Diagram of distal and proximal <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> sites on the <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> promoter region. b and c Hepa1-6 cells were transfected with reporter constructs containing wild-type (WT; white bars) and <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> binding site mutated (black bars) enhancer regions, and treated with NOB at the indicated doses. </plain></SENT>
<SENT sid="157" pm="."><plain>Co-transfection of <z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPα</z:uniprot> expression construct was also carried out in parallel. </plain></SENT>
<SENT sid="158" pm="."><plain>Each value represented mean ± SEM of three replicates from a single assay. </plain></SENT>
<SENT sid="159" pm="."><plain>The results are representative of at least three independent experiments. b and c show results from reporter constructs containing distal and proximal WT and mutant enhancers respectively. </plain></SENT>
<SENT sid="160" pm="."><plain>Two-way ANOVA with Bonferroni post-hoc tests: significant main effects of plasmid construct, (b) F = 81.43, p &lt; 0.001, (c) F = 254.97, p &lt; 0.0001; NOB concentration effect, (b) F = 47.39, p &lt; 0.0001, (c) F = 42.01, p &lt; 0.0001; and a significant interaction between constructs and NOB concentration, (b) F = 23, p &lt; 0.0001, (c) F = 24.37, p &lt; 0.0001 </plain></SENT>
</text></p></sec><sec id="Sec16"><title><text><SENT sid="161" pm="."><plain>Transcriptional regulation of other urea cycle genes by NOB under HFD </plain></SENT>
</text></title><p><text><SENT sid="162" pm="."><plain>A number of pioneering studies have provided strong evidence for co-regulation of urea cycle genes by diets, hormones, cAMP and other factors, likely as an evolutionary strategy to efficiently perform ureagenesis in response to various internal and external cues [8, 20, 35, 54–56]. </plain></SENT>
<SENT sid="163" pm="."><plain>In particular, <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> sites are found on several urea cycle genes (Fig. 5a) [7, 8]. </plain></SENT>
<SENT sid="164" pm="."><plain>Under RC, NOB treatment showed only modest effects on expression of the four other urea cycle genes (<z:uniprot sup="inside" fb="128" ids="P11725,P00481">Otc</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="P16460,P09034">Ass1</z:uniprot>, <z:uniprot sup="inside" fb="31" ids="Q91YI0,P20673">Asl</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="P0C2P2,P0C2P3">Arg1</z:uniprot>) relative to Veh controls (Fig. 5b-e). </plain></SENT>
<SENT sid="165" pm="."><plain>Strikingly, whereas HFD generally repressed their mRNA levels and also elicited strong phase shifts (Fig. 5), NOB enhanced their expression and/or amplitude, and interestingly also correct circadian phases. </plain></SENT>
<SENT sid="166" pm="."><plain>Note that a putative <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> site on the <z:uniprot sup="inside" fb="0" ids="P16460,P09034">Ass1</z:uniprot> promoter has not been reported, suggesting a secondary effect by <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> or other transcriptional mechanisms [35]. </plain></SENT>
<SENT sid="167" pm="."><plain>Since <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBPs</z:uniprot> are master regulators of overall hepatic metabolic circuits including glucose and lipid metabolism, coordinate regulation of urea cycle genes by <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBPs</z:uniprot> may enable metabolic cross-talk between nitrogen homeostasis and energy metabolism [55, 57].Fig. 5NOB coordinately enhanced urea cycle gene expression. a Diagram of <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> sites on the genomic regions for urea cycle genes including <z:uniprot sup="inside" fb="128" ids="P11725,P00481">Otc</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="P16460,P09034">Ass1</z:uniprot>, <z:uniprot sup="inside" fb="31" ids="Q91YI0,P20673">Asl</z:uniprot>, and <z:uniprot sup="inside" fb="0" ids="P0C2P2,P0C2P3">Arg1</z:uniprot>. b-e Liver samples were collected from the four diet/treatment groups of wild-type mice at the indicated circadian time points. </plain></SENT>
<SENT sid="168" pm="."><plain>Total RNAs were purified for real-time RT-PCR analysis using primers for the four urea cycle genes, including <z:uniprot sup="inside" fb="128" ids="P11725,P00481">Otc</z:uniprot> (b), Ass1c, <z:uniprot sup="inside" fb="31" ids="Q91YI0,P20673">Asl</z:uniprot> d and <z:uniprot sup="inside" fb="0" ids="P0C2P2,P0C2P3">Arg1</z:uniprot> e. RC regular chow, HFD high-fat diet, Veh vehicle, NOB Nobiletin. </plain></SENT>
<SENT sid="169" pm="."><plain>Data are presented as mean ± SEM (n = 3). </plain></SENT>
<SENT sid="170" pm="."><plain>Two-way ANOVA with Bonferroni post-hoc tests, RC.Veh vs. HFD.Veh, a p &lt; 0.0001, b p &lt; 0.01, c p &lt; 0.05, d p &lt; 0.01. </plain></SENT>
<SENT sid="171" pm="."><plain>Student’s t-test, HFD.Veh vs. HFD.NOB, *p &lt; 0.05, **p &lt; 0.01 </plain></SENT>
</text></p></sec><sec id="Sec17"><title><text><SENT sid="172" pm="."><plain>Circadian ClockΔ19/Δ19 mutant mice displayed attenuated <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> and <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> levels </plain></SENT>
</text></title><p><text><SENT sid="173" pm="."><plain>Consistent with previous studies [27, 50, 58], our data thus far indicated that both <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="P53566">Cebp</z:uniprot> genes are subjected to circadian control and display rhythmic patterns of expression. </plain></SENT>
<SENT sid="174" pm="."><plain>To directly examine whether the circadian clock plays an essential role in <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> regulation, we employed ClockΔ19/Δ19 mutant mice (<z:uniprot sup="inside" fb="0" ids="P22518,O61735">Clk</z:uniprot>) which express a dominant negative version of CLOCK proteins and thus are severely impaired in circadian rhythms [59, 60]. </plain></SENT>
<SENT sid="175" pm="."><plain>Compared with WT, <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPα</z:uniprot> <z:uniprot sup="inside" fb="15" ids="P22959,P27210,P30151,P19738,P26625,P34204,P0C9Z1,P0C9Z2,P0C9Z3,P0C9Z4,P75330,P26382,O74503,Q08747">p30</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="O02755,Q05826,P17676,P28033,P21272">C/EBPβ</z:uniprot> protein levels were markedly reduced and became largely arrhythmic in <z:uniprot sup="inside" fb="0" ids="P22518,O61735">Clk</z:uniprot> under RC feeding and constant darkness (DD) conditions (Fig. 6a and see also quantification in Additional file 1: Figure S3). </plain></SENT>
<SENT sid="176" pm="."><plain>In comparison, <z:uniprot sup="inside" fb="5" ids="P19899,P16580,Q8NFH3,Q27272">p42</z:uniprot> expression and oscillation were maintained in <z:uniprot sup="inside" fb="0" ids="P22518,O61735">Clk</z:uniprot> mice, yet interestingly displayed a reversed circadian phase pattern (Fig. 6a and Additional file 1: Figure <z:uniprot sup="inside" fb="0" ids="P42307">S3B</z:uniprot>). </plain></SENT>
<SENT sid="177" pm="."><plain>These observations illustrated gene- or isoform-specific circadian expression regulation. </plain></SENT>
<SENT sid="178" pm="."><plain>Furthermore, pronounced expression changes in <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> subunits were observed in the mutant mice, including both phase shifts and reduced levels (<z:uniprot sup="inside" fb="15" ids="P22959,P27210,P30151,P19738,P26625,P34204,P0C9Z1,P0C9Z2,P0C9Z3,P0C9Z4,P75330,P26382,O74503,Q08747">p30</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="O02755,Q05826,P17676,P28033,P21272">C/EBPβ</z:uniprot>). <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="P53566,P05554">Cebpa</z:uniprot> mRNA expression was also compromised in the mutant mice, showing strongly reduced levels and dampened circadian amplitude (Fig. 6b). </plain></SENT>
<SENT sid="179" pm="."><plain>In comparison, <z:uniprot sup="inside" fb="0" ids="P28033,P21272">Cebpb</z:uniprot> mRNA expression exhibited a marked phase shift in the mutant compared with WT (Fig. 6b, bottom), while maintaining a normal amplitude. </plain></SENT>
<SENT sid="180" pm="."><plain>Whereas <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> levels were lower in <z:uniprot sup="inside" fb="0" ids="P22518,O61735">Clk</z:uniprot> than WT, neither HFD nor NOB in mutant mice conferred significant changes (Fig. 6c; lower panel: quantification). </plain></SENT>
<SENT sid="181" pm="."><plain>These results together indicated a critical role of a functional clock to mediate NOB induction of <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot>.Fig. 6NOB restored <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="P53566">Cebp</z:uniprot> mRNA and protein levels in a clock-dependent manner. a Liver samples were collected at the indicated Circadian Times (CT) from regular chow-fed WT and Clock Δ19/Δ19 mutant (<z:uniprot sup="inside" fb="0" ids="P22518,O61735">Clk</z:uniprot>) mice (n = 3) in constant darkness (DD) when the circadian clock free runs devoid of light cue. </plain></SENT>
<SENT sid="182" pm="."><plain>CT0 corresponds to the onset of subjective day. </plain></SENT>
<SENT sid="183" pm="."><plain>Western blotting was performed using total protein extracts from the liver samples with the indicated antibodies. </plain></SENT>
<SENT sid="184" pm="."><plain>See Additional file 1: Figure S3 for quantitative analysis. b Real-time RT-PCR analysis of <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="P53566,P05554">Cebpa</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="P28033,P21272">Cebpb</z:uniprot> was carried out using total RNAs extracted from the liver samples described in (a). Data are presented as mean ± SEM. </plain></SENT>
<SENT sid="185" pm="."><plain>Two-way ANOVA with Bonferroni post-hoc tests, WT vs. <z:uniprot sup="inside" fb="0" ids="P22518,O61735">Clk</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="P28033,P21272">Cebpb</z:uniprot> p &lt; 0.01; <z:uniprot sup="inside" fb="0" ids="P53566,P05554">Cebpa</z:uniprot> p &lt; 0.05. </plain></SENT>
<SENT sid="186" pm="."><plain>Student’s t-test, WT vs. <z:uniprot sup="inside" fb="0" ids="P22518,O61735">Clk</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot>: CT4, *p &lt; 0.05; <z:uniprot sup="inside" fb="0" ids="P53566,P05554">Cebpa</z:uniprot>: <z:uniprot sup="inside" fb="0" ids="Q15431">CT8</z:uniprot>, *p &lt; 0.05; <z:uniprot sup="inside" fb="0" ids="P28033,P21272">Cebpb</z:uniprot>: <z:uniprot sup="inside" fb="0" ids="Q15431">CT8</z:uniprot>, **p &lt; 0.01. c Western blot analysis of <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> protein levels in liver samples collected at ZT8 and ZT20 from WT and <z:uniprot sup="inside" fb="0" ids="P22518,O61735">Clk</z:uniprot> mice subjected to the indicated diet and treatment. RC regular chow, HFD high-fat diet, Veh vehicle, NOB Nobiletin. </plain></SENT>
<SENT sid="187" pm="."><plain>Two-way ANOVA with Bonferroni post-hoc tests, WT vs. individual <z:uniprot sup="inside" fb="0" ids="P22518,O61735">Clk</z:uniprot> groups, *p &lt; 0.05 </plain></SENT>
</text></p></sec><sec id="Sec18"><title><text><SENT sid="188" pm="."><plain>NOB modulated serum and urine urea content </plain></SENT>
</text></title><p><text><SENT sid="189" pm="."><plain>Finally, to further elucidate a modulatory role of NOB in nitrogen homeostasis, we measured urea content in serum and urine at both day- and night-time. </plain></SENT>
<SENT sid="190" pm="."><plain>In RC, serum urea levels were mildly reduced in the NOB group at both day- and night-time (ZT6 and 18) (Fig. 7a), whereas the urine urea levels showed the opposite trend, suggesting increased urine urea excretion by NOB (Fig. 7b). </plain></SENT>
<SENT sid="191" pm="."><plain>In comparison, HFD feeding led to lower serum urea levels than RC (Fig. 7a). </plain></SENT>
<SENT sid="192" pm="."><plain>More importantly, HFD showed a reverse NOB response; specifically, NOB increased serum urea and concomitantly reduced renal urea excretion, particularly at ZT18 (Fig. 7b). </plain></SENT>
<SENT sid="193" pm="."><plain>These results further illustrated a modulatory role of NOB in nitrogen homeostasis.Fig. 7Effects of NOB on urea production. a and b Serum (a) and urine (b) urea levels at ZT6 and ZT18 in WT mice treated with Veh or NOB under RC (n = 7) or HFD (n = 4). </plain></SENT>
<SENT sid="194" pm="."><plain>Data are presented as mean ± SEM. </plain></SENT>
<SENT sid="195" pm="."><plain>Student’s t-test, Veh vs. NOB, *p &lt;0.05; RC vs. HFD, †p &lt;0.05, ††p &lt;0.01 </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec id="Sec19" sec-type="discussion"><title><text><SENT sid="196" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="197" pm="."><plain>In the current study, we demonstrated a broad effect of the natural flavonoid NOB in reducing serum ammonia levels under varying diet conditions. </plain></SENT>
<SENT sid="198" pm="."><plain>NOB and other related polymethoxylated flavonoids are dietary components generally showing favorable pharmacokinetic profiles [61, 62], and mouse and human studies revealed promising efficacy of NOB against the metabolic syndrome without significant toxicity [40, 44, 45, 63]. </plain></SENT>
<SENT sid="199" pm="."><plain>The current work illustrated a novel function of NOB in ammonia disposal, extending the long list of physiological benefits associated with NOB and other natural flavonoids [63, 64]. </plain></SENT>
<SENT sid="200" pm="."><plain>In light of these beneficial attributes, it warrants further investigation whether NOB can be incorporated into dietary management for congenital and injury-induced hyperammonemia. </plain></SENT>
</text></p><p><text><SENT sid="201" pm="."><plain>Our study revealed broad ammonia-lowering activities of NOB in mice fed with RC, HFD or <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot>, ostensibly utilizing distinct, diet-specific mechanisms. </plain></SENT>
<SENT sid="202" pm="."><plain>Whereas transcriptional activation of <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> via <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> induction seems to operate under HFD, NOB treatment in conjunction with RC and <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot> feeding appeared not to elicit significant <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> induction. </plain></SENT>
<SENT sid="203" pm="."><plain>Moreover, in contrast to RC where NOB similarly reduced serum ammonia at both ZT6 and ZT18, in HFD and <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot> NOB more strongly diminished the relative high ammonia levels in respective diets (ZT6 for HFD and ZT18 for <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot>). </plain></SENT>
<SENT sid="204" pm="."><plain>As a result, NOB functions to reverse the exaggerated ammonia variation between the active and inactive phases, essentially normalizing circadian ammonia rhythm in HFD and <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot> to RC levels. </plain></SENT>
<SENT sid="205" pm="."><plain>Given the remarkably diverse cellular pathways known to be modulated by NOB and other flavonoids, various molecular and cellular mechanisms may underlie such mechanistic and functional plasticity [63–67]. </plain></SENT>
<SENT sid="206" pm="."><plain>Besides transcriptional regulation (<z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot>, <z:uniprot sup="inside" fb="0" ids="P79686,Q6XLJ0,P49115,P04150,P06537,P49843,O73673,Q9N1U3,Q5R9P5,P59667,P06536,P79269,O13186,O46567,P35547,Q95267,P49844">glucocorticoid receptor</z:uniprot>, CREB and HNF3) and the allosteric cofactor <z:uniprot sup="inside" fb="117" ids="P54802,A2RRP1">NAG</z:uniprot> [7, 17], recent mechanistic studies have also underscored the importance of post-translational modifications (PTMs) for <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> protein activity [11–13, 47]. </plain></SENT>
<SENT sid="207" pm="."><plain>Other urea cycle genes may also serve as the primary target; one such candidate is <z:uniprot sup="inside" fb="128" ids="P11725,P00481">Otc</z:uniprot>, especially given its functional connection with the circadian clock [19]. </plain></SENT>
<SENT sid="208" pm="."><plain>Finally, NOB may also attenuate <z:uniprot sup="inside" fb="7" ids="P93836,Q5EA20,Q60Y65,Q22633,Q1E803,P0CW94,E9CWP5,Q6TGZ5,O23920,Q76NV5,O48604,P32754,Q96X22,P49429,Q872T7,Q02110,Q9ARF9,Q9I576,P80064,P32755,Q53586,Q9S2F4,Q27203,Q5BKL0,Q6CDR5,O42764,P69053,Q5ZT84">HPD</z:uniprot>-induced bacterial production of ammonia by amino acid deamination and urea hydrolysis [4]. </plain></SENT>
</text></p><p><text><SENT sid="209" pm="."><plain>Our analysis revealed differential responses of serum and urine urea levels to NOB treatment in HFD. </plain></SENT>
<SENT sid="210" pm="."><plain>Urea represents the most predominant circulating nitrogen reservoir, and blood urea nitrogen (BUN) level is known to be regulated by multiple factors including protein intake, protein metabolism and renal function [1, 5]. </plain></SENT>
<SENT sid="211" pm="."><plain>HFD contains lower protein content than RC (20 % vs. 29 % in calories), and NOB acts to attenuate ammonia levels by activating urea cycle gene expression. </plain></SENT>
<SENT sid="212" pm="."><plain>Thus, urea may be salvaged to maintain nitrogen balance in the HFD.NOB condition. </plain></SENT>
<SENT sid="213" pm="."><plain>For example, urine excretion rate/volume and renal reabsorption of water/mineral/urea are tightly coupled to regulate osmotic pressure, which may in turn modulate serum and urine urea levels. </plain></SENT>
<SENT sid="214" pm="."><plain>However, a direct role of NOB in renal function remains to be elucidated. </plain></SENT>
</text></p><p><text><SENT sid="215" pm="."><plain>Amino acid levels in human blood have been shown to exhibit robust circadian oscillation, concordant with results from a yeast metabolic cycle resembling mammalian circadian rhythm [68–70]. </plain></SENT>
<SENT sid="216" pm="."><plain>In parallel with fluctuating amino acid levels over the daily cycle, <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> and several other urea cycle components exhibited circadian mRNA and protein expression patterns [27]. </plain></SENT>
<SENT sid="217" pm="."><plain>However, much conflictory evidence has also been reported with regard to <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> circadian expression [26, 28, 29]. </plain></SENT>
<SENT sid="218" pm="."><plain>Our experiments, using specific primers and antibodies, revealed weak oscillation of <z:uniprot sup="inside" fb="0" ids="P0CH42">Cps1</z:uniprot> mRNA and protein. </plain></SENT>
<SENT sid="219" pm="."><plain>Interestingly, NOB appeared to augment <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> protein oscillation under RC, and also enhanced <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> levels under HFD in a circadian clock-dependent manner. </plain></SENT>
<SENT sid="220" pm="."><plain>One possible mechanism of circadian regulation may depend on <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBPs</z:uniprot> as their expression is subjected to clock control [50], although other mechanisms likely exist [19]. </plain></SENT>
<SENT sid="221" pm="."><plain>Of note, we observed distinct circadian changes of <z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPα</z:uniprot> <z:uniprot sup="inside" fb="5" ids="P19899,P16580,Q8NFH3,Q27272">p42</z:uniprot> and <z:uniprot sup="inside" fb="15" ids="P22959,P27210,P30151,P19738,P26625,P34204,P0C9Z1,P0C9Z2,P0C9Z3,P0C9Z4,P75330,P26382,O74503,Q08747">p30</z:uniprot> isoforms in ClockΔ19/Δ19 mutant mice relative to WT, suggesting a possible circadian regulation of alternative translation. </plain></SENT>
<SENT sid="222" pm="."><plain>Currently, work in our lab aims to further understand the detailed mechanism underlying the interaction between the clock, diet and NOB in nitrogen homeostasis. </plain></SENT>
</text></p></sec></SecTag><SecTag type="CONCL"><sec id="Sec20" sec-type="conclusions"><title><text><SENT sid="223" pm="."><plain>Conclusion </plain></SENT>
</text></title><p><text><SENT sid="224" pm="."><plain>In this current study, we present physiological evidence indicating that NOB exhibits a broad activity in ammonia control in mice fed with varying diets. </plain></SENT>
<SENT sid="225" pm="."><plain>Molecular experiments further revealed that NOB regulates urea cycle function via <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot>- and circadian clock-dependent regulatory mechanisms. </plain></SENT>
<SENT sid="226" pm="."><plain>These observations together demonstrate a novel physiological function and cellular mechanism of a natural dietary flavonoid in nitrogen homeostasis. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="APPENDIX"><app-group><app id="App1"><sec id="Sec21"><title>Additional file</title><p><media position="anchor" xlink:href="12986_2015_20_MOESM1_ESM.pdf" id="MOESM1"><label>Additional file 1: Table S1.</label><caption><p><text><SENT sid="227" pm="."><plain>Primers for construction of reporter constructs. Table S2. Primers for real-time qPCR analysis. Table S3. Mass spectrometry data table for the 164KD band shown in the Additional file 1: Figure <z:uniprot sup="inside" fb="0" ids="P47835">S1B</z:uniprot>. Figure S1. NOB modulates <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> expression. (A) Quantification of <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> protein levels from three independent experiments including the blot shown in Fig. 2a. </plain></SENT>
<SENT sid="228" pm="."><plain>RC, regular chow; HFD, high-fat diet; Veh, vehicle; NOB, Nobiletin. </plain></SENT>
<SENT sid="229" pm="."><plain>Two-way ANOVA with Bonferroni post-hoc tests shows significant statistical differences between HFD.Veh and other three groups (p &lt; 0.0001). </plain></SENT>
<SENT sid="230" pm="."><plain>Furthermore, one-way ANOVA with Bonferroni tests shows significant difference (p &lt; 0.05) between ZT time points in RC.Veh but not in other groups. (B) Coomassie blue staining of <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot>. </plain></SENT>
<SENT sid="231" pm="."><plain>Mouse liver protein lysates were separated on SDS-PAGE gel and stained with Coomassie blue. </plain></SENT>
<SENT sid="232" pm="."><plain>The predominant 164KD band was validated by mass spectrometry as <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> (Table S3). (C) Control microscopy images for Fig. 2b using rabbit IgG. Figure S2. NOB rescued <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> protein circadian expression in the liver from HFD fed mice. (A) Quantification of <z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPα</z:uniprot> <z:uniprot sup="inside" fb="5" ids="P19899,P16580,Q8NFH3,Q27272">p42</z:uniprot> protein levels from three independent experiments including the blot shown in Fig. 3b. </plain></SENT>
<SENT sid="233" pm="."><plain>Two-way ANOVA with Bonferroni post-hoc tests shows significant difference between RC.Veh and HFD.Veh (p &lt; 0.05), indicating diet effect on the <z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPα</z:uniprot> <z:uniprot sup="inside" fb="5" ids="P19899,P16580,Q8NFH3,Q27272">p42</z:uniprot> expression level. </plain></SENT>
<SENT sid="234" pm="."><plain>Importantly, RC.NOB was not significantly different from HFD.NOB, suggesting NOB reversed the reducing effect of HFD on the <z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPα</z:uniprot> <z:uniprot sup="inside" fb="5" ids="P19899,P16580,Q8NFH3,Q27272">p42</z:uniprot> expression. (B) Quantification of <z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPα</z:uniprot> <z:uniprot sup="inside" fb="0" ids="P0A424,P23077,P12975,P0A423,P20900">p30 protein</z:uniprot> levels from three independent experiments including the blot shown in Fig. 3b. </plain></SENT>
<SENT sid="235" pm="."><plain>Two-way ANOVA with Bonferroni post-hoc tests shows significant difference between RC.Veh and HFD.Veh (p &lt; 0.01), but RC.NOB and HFD.NOB was not significantly different, again suggesting NOB reversed the reducing effect of HFD on the <z:uniprot sup="inside" fb="15" ids="P22959,P27210,P30151,P19738,P26625,P34204,P0C9Z1,P0C9Z2,P0C9Z3,P0C9Z4,P75330,P26382,O74503,Q08747">p30</z:uniprot> expression. (C) Quantification of <z:uniprot sup="inside" fb="0" ids="O02755,Q05826,P17676,P28033,P21272">C/EBPβ</z:uniprot> protein levels from three independent experiments including the blot shown in Fig. 3b. </plain></SENT>
<SENT sid="236" pm="."><plain>Two-way ANOVA with Bonferroni post-hoc tests shows significant difference between RC.Veh and HFD.Veh (p &lt; 0.0001), but RC.NOB and HFD.NOB was not significantly different. Figure S3. NOB restored <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> and <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot> protein levels in a clock-dependent manner. (A) Quantification of <z:uniprot sup="inside" fb="0" ids="P26990,A0A1D6LAG9,Q6ET36,P31327,Q38802,J9QS23">CPS1</z:uniprot> protein levels under constant darkness (DD) conditions from three independent experiments including the blot shown in Fig. 6a. </plain></SENT>
<SENT sid="237" pm="."><plain>Two-way ANOVA with Bonferroni post-hoc tests shows significant statistical difference between WT and <z:uniprot sup="inside" fb="0" ids="P22518,O61735">Clk</z:uniprot> (Clock Δ19/Δ19) (p &lt; 0.0001). (B) Quantification of <z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPα</z:uniprot> <z:uniprot sup="inside" fb="5" ids="P19899,P16580,Q8NFH3,Q27272">p42</z:uniprot> protein levels under constant darkness (DD) conditions from three independent experiments including the blot shown in Fig. 6a. </plain></SENT>
<SENT sid="238" pm="."><plain>Two-way ANOVA with Bonferroni post-hoc tests shows significant statistical differences between WT and <z:uniprot sup="inside" fb="0" ids="P22518,O61735">Clk</z:uniprot> (p &lt; 0.05). (C) Quantification of <z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPα</z:uniprot> <z:uniprot sup="inside" fb="0" ids="P0A424,P23077,P12975,P0A423,P20900">p30 protein</z:uniprot> levels under constant darkness (DD) conditions from three independent experiments including the blot shown in Fig. 6a. </plain></SENT>
<SENT sid="239" pm="."><plain>Two-way ANOVA with Bonferroni post-hoc tests shows significant statistical difference between WT and <z:uniprot sup="inside" fb="0" ids="P22518,O61735">Clk</z:uniprot> (p &lt; 0.01). (D) Quantification of <z:uniprot sup="inside" fb="0" ids="O02755,Q05826,P17676,P28033,P21272">C/EBPβ</z:uniprot> protein levels under constant darkness (DD) conditions from three independent experiments including the blot shown in Fig. 6a. </plain></SENT>
<SENT sid="240" pm="."><plain>Two-way ANOVA with Bonferroni post-hoc tests shows significant statistical difference between WT and <z:uniprot sup="inside" fb="0" ids="P22518,O61735">Clk</z:uniprot> (p &lt; 0.05). </plain></SENT>
</text></p></caption></media></p></sec></app></app-group></SecTag><SecTag type="ABBR"><glossary><title>Abbreviations</title><def-list><def-item><term>CPS1</term><def><p>Carbamoyl phosphate synthetase 1</p></def></def-item><def-item><term>RC</term><def><p>Regular chow</p></def></def-item><def-item><term>HFD</term><def><p>High-fat diet</p></def></def-item><def-item><term>Veh</term><def><p>Vehicle</p></def></def-item><def-item><term>NOB</term><def><p>Nobiletin</p></def></def-item><def-item><term>HPD</term><def><p>High-protein diet</p></def></def-item><def-item><term>NAG</term><def><p>N-acetylglutamate</p></def></def-item><def-item><term>ZT</term><def><p>Zeitgeber time</p></def></def-item><def-item><term>OTC</term><def><p>Ornithine transcarbamylase</p></def></def-item><def-item><term>C/EBP</term><def><p>CCAAT/enhancer binding protein</p></def></def-item><def-item><term>WT</term><def><p>Wild-type</p></def></def-item><def-item><term>Clk</term><def><p><italic>Clock</italic><sup><italic>Δ19/Δ19</italic></sup> mutant</p></def></def-item><def-item><term>PTMs</term><def><p>Post-translational modifications</p></def></def-item></def-list></glossary></SecTag><fn-group><fn><p><text><SENT sid="241" pm="."><plain>Kazunari Nohara and Youngmin Shin contributed equally to this work. </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="242" pm="."><plain>Competing interests </plain></SENT>
</text></p><p><text><SENT sid="243" pm="."><plain>The authors declare no competing interests. </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="244" pm="."><plain>Authors’ contributions </plain></SENT>
</text></p><p><text><SENT sid="245" pm="."><plain>KN and BH carried out the physiological assays. </plain></SENT>
<SENT sid="246" pm="."><plain>YS, NP and KJ carried out the molecular studies. </plain></SENT>
<SENT sid="247" pm="."><plain>NK analyzed promoter sequences and gene expression. </plain></SENT>
<SENT sid="248" pm="."><plain>KN, NP and SY performed the statistical analysis. </plain></SENT>
<SENT sid="249" pm="."><plain>SY and ZC conceived of the study, and participated in its design and coordination and drafted the manuscript. </plain></SENT>
<SENT sid="250" pm="."><plain>All authors read and approved the final manuscript. </plain></SENT>
</text></p></fn></fn-group><SecTag type="ACK_FUND"><ack><title>Acknowledgements</title><p><text4fund><text><SENT sid="251" pm="."><plain>We thank <z:uniprot sup="inside" fb="84" ids="P41964,Q63769">Drs</z:uniprot>. </plain></SENT>
<SENT sid="252" pm="."><plain>W. </plain></SENT>
<SENT sid="253" pm="."><plain>Leng and J. </plain></SENT>
<SENT sid="254" pm="."><plain>Qin for mass spectrometry and Dr. Matthew Hirschey for helpful discussions. </plain></SENT>
<SENT sid="255" pm="."><plain>This work was in part supported by the Robert A. </plain></SENT>
<SENT sid="256" pm="."><plain>Welch Foundation (AU-1731), American Heart Association (11SDG7600045), NIH/<z:uniprot sup="inside" fb="16" ids="P43100,P43101,P39863,P39869,P39882,P36859,P17570,P23312">NIA</z:uniprot> (R01 AG045828) to Z.C., NIH/NIGMS (R01 GM114424) to S.-H.Y., <z:uniprot sup="inside" fb="10" ids="P46977">TMC</z:uniprot>-<z:uniprot sup="inside" fb="6" ids="P27718,P34751,P22781,O96571,P05031,O96567,P20711,P48861,O88533,P80041,P14173">DDC</z:uniprot> P/F Awards to S.-H.Y. and Z.C. </plain></SENT>
<SENT sid="257" pm="."><plain>(NIDDK Center Grant P30-DK056338), and JSPS KAKENHI (26293048) and the Uehara Memorial Foundation to N.K. </plain></SENT>
<SENT sid="258" pm="."><plain>The funding agencies have no role in experimental design, execution, data analysis and manuscript preparation. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="REF"><ref-list id="Bib1"><title>References</title><ref id="CR1"><text><SENT sid="259" pm="."><plain>1.AdevaMMSoutoGBlancoNDonapetryCAmmonium metabolism in humansMetab Clin Exp201261149551110.1016/j.metabol.2012.07.00722921946 </plain></SENT>
</text></ref><ref id="CR2"><text><SENT sid="260" pm="."><plain>2.BraissantOCurrent concepts in the pathogenesis of urea cycle disordersMol Genet Metab2010100Suppl 1S31210.1016/j.ymgme.2010.02.01020227314 </plain></SENT>
</text></ref><ref id="CR3"><text><SENT sid="261" pm="."><plain>3.AuronABrophyPDHyperammonemia in review: pathophysiology, diagnosis, and treatmentPediatr Nephrol2012272072210.1007/s00467-011-1838-521431427 </plain></SENT>
</text></ref><ref id="CR4"><text><SENT sid="262" pm="."><plain>4.VinceAJBurridgeSMAmmonia production by intestinal bacteria: the effects of lactose, lactulose and glucoseJ Med Microbiol1980131779110.1099/00222615-13-2-1777381915 </plain></SENT>
</text></ref><ref id="CR5"><text><SENT sid="263" pm="."><plain>5.WeinerIDMitchWESandsJMUrea and ammonia metabolism and the control of renal nitrogen excretion. </plain></SENT>
<SENT sid="264" pm="."><plain>Clinical Journal of the American Society of Nephrology: CJASN2014 </plain></SENT>
</text></ref><ref id="CR6"><text><SENT sid="265" pm="."><plain>6.HaberleJClinical and biochemical aspects of primary and secondary hyperammonemic disordersArch Biochem Biophys2013536101810.1016/j.abb.2013.04.00923628343 </plain></SENT>
</text></ref><ref id="CR7"><text><SENT sid="266" pm="."><plain>7.MorrisSMJrRegulation of enzymes of the urea cycle and arginine metabolismAnnu Rev Nutr2002228710510.1146/annurev.nutr.22.110801.14054712055339 </plain></SENT>
</text></ref><ref id="CR8"><text><SENT sid="267" pm="."><plain>8.TakiguchiMMoriMTranscriptional regulation of genes for ornithine cycle enzymesBiochem J1995312Pt 3649598554501 </plain></SENT>
</text></ref><ref id="CR9"><text><SENT sid="268" pm="."><plain>9.SchofieldJPCoxTMCaskeyCTWakamiyaMMice deficient in the urea-cycle enzyme, <z:uniprot sup="inside" fb="0" ids="P31327,Q91293,Q8C196,P07756">carbamoyl phosphate synthetase I</z:uniprot>, die during the early neonatal period from hyperammonemiaHepatology199929181510.1002/<z:uniprot sup="inside" fb="21" ids="Q23977">hep</z:uniprot>.5102901129862865 </plain></SENT>
</text></ref><ref id="CR10"><text><SENT sid="269" pm="."><plain>10.MartinezAIPerez-ArellanoIPekkalaSBarcelonaBCerveraJGenetic, structural and biochemical basis of <z:uniprot sup="inside" fb="0" ids="A5UK38">carbamoyl phosphate synthetase</z:uniprot> 1 deficiencyMol Genet Metab20101013112310.1016/j.ymgme.2010.08.00220800523 </plain></SENT>
</text></ref><ref id="CR11"><text><SENT sid="270" pm="."><plain>11.CorviMMSoltysCLBerthiaumeLGRegulation of mitochondrial <z:uniprot sup="inside" fb="0" ids="A5UK38">carbamoyl-phosphate synthetase</z:uniprot> 1 activity by active site fatty acylationJ Biol Chem2001276457041210.1074/jbc.M10276620011577071 </plain></SENT>
</text></ref><ref id="CR12"><text><SENT sid="271" pm="."><plain>12.NakagawaTLombDJHaigisMCGuarenteLSIRT5 deacetylates <z:uniprot sup="inside" fb="0" ids="A5UK38">carbamoyl phosphate synthetase</z:uniprot> 1 and regulates the urea cycleCell20091375607010.1016/j.cell.2009.02.02619410549 </plain></SENT>
</text></ref><ref id="CR13"><text><SENT sid="272" pm="."><plain>13.TanMPengCAndersonKAChhoyPXieZDaiLLysine glutarylation is a protein posttranslational modification regulated by SIRT5Cell Metab2014196051710.1016/j.cmet.2014.03.01424703693 </plain></SENT>
</text></ref><ref id="CR14"><text><SENT sid="273" pm="."><plain>14.Beliveau CareyGCheungCWCohenNSBrusilowSRaijmanLRegulation of urea and citrulline synthesis under physiological conditionsBiochem J1993292Pt 124178503852 </plain></SENT>
</text></ref><ref id="CR15"><text><SENT sid="274" pm="."><plain>15.ChristoffelsVMvan den HoffMJLamersMCvan RoonMAde BoerPAMoormanAFThe upstream regulatory region of the <z:uniprot sup="inside" fb="0" ids="P31327,Q91293,Q8C196,P07756">carbamoyl-phosphate synthetase I</z:uniprot> gene controls its tissue-specific, developmental, and hormonal regulation in vivoJ Biol Chem1996271312435010.1074/jbc.271.49.312438940127 </plain></SENT>
</text></ref><ref id="CR16"><text><SENT sid="275" pm="."><plain>16.ChenYRSekineKNakamuraKYanaiHTanakaMMiyajimaAY-box binding <z:uniprot sup="inside" fb="0" ids="Q8V3T6">protein-1</z:uniprot> down-regulates expression of <z:uniprot sup="inside" fb="0" ids="P31327,Q91293,Q8C196,P07756">carbamoyl phosphate synthetase-I</z:uniprot> by suppressing CCAAT enhancer-binding protein-alpha function in miceGastroenterology20091373304010.1053/j.gastro.2009.02.06419272383 </plain></SENT>
</text></ref><ref id="CR17"><text><SENT sid="276" pm="."><plain>17.UlbrightCSnodgrassPJCoordinate induction of the urea cycle enzymes by glucagon and dexamethasone is accomplished by three different mechanismsArch Biochem Biophys19933012374310.1006/abbi.1993.11398460937 </plain></SENT>
</text></ref><ref id="CR18"><text><SENT sid="277" pm="."><plain>18.BassJTakahashiJSCircadian integration of metabolism and energeticsScience201033013495410.1126/science.119502721127246 </plain></SENT>
</text></ref><ref id="CR19"><text><SENT sid="278" pm="."><plain>19.JeyarajDScheerFARippergerJAHaldarSMLuYProsdocimoDAKlf15 orchestrates circadian nitrogen homeostasisCell Metab2012153112310.1016/j.cmet.2012.01.02022405069 </plain></SENT>
</text></ref><ref id="CR20"><text><SENT sid="279" pm="."><plain>20.PandaSAntochMPMillerBHSuAISchookABStraumeMCoordinated transcription of key pathways in the mouse by the circadian clockCell20021093072010.1016/S0092-8674(02)00722-512015981 </plain></SENT>
</text></ref><ref id="CR21"><text><SENT sid="280" pm="."><plain>21.LeftaMWolffGEsserKACircadian rhythms, the molecular clock, and skeletal muscleCurr Top Dev Biol2011962317121621073 </plain></SENT>
</text></ref><ref id="CR22"><text><SENT sid="281" pm="."><plain>22.NoharaKYooSHChenZJManipulating the circadian and sleep cycles to protect against metabolic diseaseFront Endocrinol201563510.3389/fendo.2015.00035 </plain></SENT>
</text></ref><ref id="CR23"><text><SENT sid="282" pm="."><plain>23.FuentesJMPascualMRSalidoGSolerGMadridJAOscillations in rat liver cytosolic enzyme activities of the urea cycleArch Int Physiol Biochim Biophys19941022374110.3109/138134594090039367849268 </plain></SENT>
</text></ref><ref id="CR24"><text><SENT sid="283" pm="."><plain>24.PriceGMHallidayDPacyPJQuevedoMRMillwardDJNitrogen homeostasis in man: influence of protein intake on the amplitude of diurnal cycling of body nitrogenClin Sci199486911028306557 </plain></SENT>
</text></ref><ref id="CR25"><text><SENT sid="284" pm="."><plain>25.KajimuraMIwataKNumataHDiurnal nitrogen excretion rhythm of the functionally ureogenic gobiid fish Mugilogobius abei. </plain></SENT>
<SENT sid="285" pm="."><plain>Comparative biochemistry and physiologyPart B, Biochem Mol20021312273910.1016/S1096-4959(01)00503-6 </plain></SENT>
</text></ref><ref id="CR26"><text><SENT sid="286" pm="."><plain>26.MasriSPatelVREckel-MahanKLPelegSForneILadurnerAGCircadian acetylome reveals regulation of mitochondrial metabolic pathwaysProc Natl Acad Sci U S A201311033394410.1073/pnas.121763211023341599 </plain></SENT>
</text></ref><ref id="CR27"><text><SENT sid="287" pm="."><plain>27.ReddyABKarpNAMaywoodESSageEADeeryMO’NeillJSCircadian orchestration of the hepatic proteomeCurr Biol20061611071510.1016/j.cub.2006.04.02616753565 </plain></SENT>
</text></ref><ref id="CR28"><text><SENT sid="288" pm="."><plain>28.HughesMEDiTacchioLHayesKRVollmersCPulivarthySBaggsJEHarmonics of circadian gene transcription in mammalsPLoS Genet2009510.1371/journal.pgen.1000442 </plain></SENT>
</text></ref><ref id="CR29"><text><SENT sid="289" pm="."><plain>29.KoikeNYooSHHuangHCKumarVLeeCKimTKTranscriptional architecture and chromatin landscape of the core circadian clock in mammalsScience20123383495410.1126/science.122633922936566 </plain></SENT>
</text></ref><ref id="CR30"><text><SENT sid="290" pm="."><plain>30.RoseCFAmmonia-lowering strategies for the treatment of hepatic encephalopathyClin Pharmacol Ther2012923213110.1038/clpt.2012.11222871998 </plain></SENT>
</text></ref><ref id="CR31"><text><SENT sid="291" pm="."><plain>31.SinghRHNutritional management of patients with urea cycle disordersJ Inherit Metab Dis200730880710.1007/s10545-007-0718-418034368 </plain></SENT>
</text></ref><ref id="CR32"><text><SENT sid="292" pm="."><plain>32.MariniJCLeeBGarlickPJOrnithine restores ureagenesis capacity and mitigates hyperammonemia in <z:uniprot sup="inside" fb="128" ids="P11725,P00481">Otc</z:uniprot>(spf-ash) miceJ Nutr20061361834816772445 </plain></SENT>
</text></ref><ref id="CR33"><text><SENT sid="293" pm="."><plain>33.CamachoJAObieCBieryBGoodmanBKHuCAAlmashanuSHyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporterNat Genet199922151810.1038/965810369256 </plain></SENT>
</text></ref><ref id="CR34"><text><SENT sid="294" pm="."><plain>34.de Castro GhizoniCVGasparinFRJuniorASCarrenoFOConstantinRPBrachtACatabolism of amino acids in livers from cafeteria-fed ratsMol Cell Biochem20133732657710.1007/s11010-012-1499-023117227 </plain></SENT>
</text></ref><ref id="CR35"><text><SENT sid="295" pm="."><plain>35.ChristoffelsVMGrangeTKaestnerKHColeTJDarlingtonGJCronigerCMGlucocorticoid receptor, <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot>, HNF3, and <z:uniprot sup="inside" fb="0" ids="Q9RI12,Q05608">protein kinase A</z:uniprot> coordinately activate the glucocorticoid response unit of the <z:uniprot sup="inside" fb="0" ids="P31327,Q91293,Q8C196,P07756">carbamoylphosphate synthetase I</z:uniprot> geneMol Cell Biol1998186305159774647 </plain></SENT>
</text></ref><ref id="CR36"><text><SENT sid="296" pm="."><plain>36.ChenZYooSHParkYSKimKHWeiSBuhrEIdentification of diverse modulators of central and peripheral circadian clocks by high-throughput chemical screeningProc Natl Acad Sci U S A2012109101610.1073/pnas.111803410822184224 </plain></SENT>
</text></ref><ref id="CR37"><text><SENT sid="297" pm="."><plain>37.YooSHYamazakiSLowreyPLShimomuraKKoCHBuhrEDPERIOD2:: LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissuesProc Natl Acad Sci U S A200410153394610.1073/pnas.030870910114963227 </plain></SENT>
</text></ref><ref id="CR38"><text><SENT sid="298" pm="."><plain>38.YooSHMohawkJASiepkaSMShanYHuhSKHongHKCompeting E3 <z:uniprot sup="inside" fb="2" ids="P69310,Q865C5,P68197,P19848,Q8SWD4,P69313,P84589,P69317,P62975,P69326">ubiquitin</z:uniprot> ligases govern circadian periodicity by degradation of CRY in nucleus and cytoplasmCell2013152109110510.1016/j.cell.2013.01.05523452855 </plain></SENT>
</text></ref><ref id="CR39"><text><SENT sid="299" pm="."><plain>39.MalovannayaALanzRBJungSYBulynkoYLeNTChanDWAnalysis of the human endogenous coregulator complexomeCell20111457879910.1016/j.cell.2011.05.00621620140 </plain></SENT>
</text></ref><ref id="CR40"><text><SENT sid="300" pm="."><plain>40.WalleTMethoxylated flavones, a superior cancer chemopreventive flavonoid subclass?Semin Cancer Biol2007173546210.1016/j.semcancer.2007.05.00217574860 </plain></SENT>
</text></ref><ref id="CR41"><text><SENT sid="301" pm="."><plain>41.CuiYWuJJungSCParkDBMaengYHHongJYAnti-neuroinflammatory activity of nobiletin on suppression of microglial activationBiol Pharm Bull20103318142110.1248/bpb.33.181421048305 </plain></SENT>
</text></ref><ref id="CR42"><text><SENT sid="302" pm="."><plain>42.KurowskaEMMantheyJAHypolipidemic effects and absorption of citrus polymethoxylated flavones in hamsters with diet-induced hypercholesterolemiaJ Agric Food Chem20045228798610.1021/jf035354z15137829 </plain></SENT>
</text></ref><ref id="CR43"><text><SENT sid="303" pm="."><plain>43.KimKHParkYFood components with anti-obesity effectAnnu Rev Food Sci Technol201122375710.1146/annurev-food-022510-13365622129382 </plain></SENT>
</text></ref><ref id="CR44"><text><SENT sid="304" pm="."><plain>44.MulvihillEEAssiniJMLeeJKAllisterEMSutherlandBGKoppesJBNobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistanceDiabetes20116014465710.2337/db10-058921471511 </plain></SENT>
</text></ref><ref id="CR45"><text><SENT sid="305" pm="."><plain>45.LeeYSChaBYChoiSSChoiBKYonezawaTTeruyaTNobiletin improves obesity and insulin resistance in high-fat diet-induced obese miceJ Nutr Biochem2013241566210.1016/j.jnutbio.2012.03.01422898571 </plain></SENT>
</text></ref><ref id="CR46"><text><SENT sid="306" pm="."><plain>46.LeeYSChaBYSaitoKYamakawaHChoiSSYamaguchiKNobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob miceBiochem Pharmacol20107916748310.1016/j.<z:uniprot sup="inside" fb="88" ids="P19567,Q796Y8,Q9ZHF0,Q83CY8,P0AE54,P0AE53,P0AE52,P44411,Q9ZMU4,P55979,P9WIE0,P9WIE1,P0AE55,Q8P9V9">bcp</z:uniprot>.2010.01.03420144590 </plain></SENT>
</text></ref><ref id="CR47"><text><SENT sid="307" pm="."><plain>47.KendrickAAChoudhuryMRahmanSMMcCurdyCEFriederichMVan HoveJLFatty liver is associated with reduced <z:uniprot sup="inside" fb="0" ids="Q9NTG7">SIRT3</z:uniprot> activity and mitochondrial protein hyperacetylationBiochem J20114335051410.1042/BJ2010079121044047 </plain></SENT>
</text></ref><ref id="CR48"><text><SENT sid="308" pm="."><plain>48.WangNDFinegoldMJBradleyAOuCNAbdelsayedSVWildeMDImpaired energy homeostasis in <z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBP alpha</z:uniprot> knockout miceScience199526911081210.1126/science.76525577652557 </plain></SENT>
</text></ref><ref id="CR49"><text><SENT sid="309" pm="."><plain>49.TanakaTYoshidaNKishimotoTAkiraSDefective adipocyte differentiation in mice lacking the <z:uniprot sup="inside" fb="0" ids="O02755,Q05826,P17676,P28033,P21272">C/EBPbeta</z:uniprot> and/or <z:uniprot sup="inside" fb="0" ids="O02756,P49716,Q00322,Q03484,Q9N0J3">C/EBPdelta</z:uniprot> geneEMBO J19971674324310.1093/emboj/16.24.74329405372 </plain></SENT>
</text></ref><ref id="CR50"><text><SENT sid="310" pm="."><plain>50.KawasakiHDoiRItoKShimodaMIshidaNThe circadian binding of CLOCK protein to the promoter of C/ebpalpha gene in mouse cellsPLoS One2013810.1371/journal.pone.0058221 </plain></SENT>
</text></ref><ref id="CR51"><text><SENT sid="311" pm="."><plain>51.RamjiDPFokaPCCAAT/enhancer-binding proteins: structure, function and regulationBiochem J20023655617512006103 </plain></SENT>
</text></ref><ref id="CR52"><text><SENT sid="312" pm="."><plain>52.RahmanSMJanssenRCChoudhuryMBaqueroKCAikensRMde la HoussayeBACCAAT/enhancer-binding protein beta (<z:uniprot sup="inside" fb="0" ids="O02755,Q05826,P17676,P28033,P21272">C/EBPbeta</z:uniprot>) expression regulates dietary-induced inflammation in macrophages and adipose tissue in miceJ Biol Chem2012287343496010.1074/jbc.M112.41061322902781 </plain></SENT>
</text></ref><ref id="CR53"><text><SENT sid="313" pm="."><plain>53.LagaceMGopingISMuellerCRLazzaroMShoreGCThe carbamyl phosphate synthetase promoter contains multiple binding sites for <z:uniprot sup="inside" fb="8" ids="Q02637,Q02638">C/EBP</z:uniprot>-related proteinsGene1992118231810.1016/0378-1119(92)90193-S1511897 </plain></SENT>
</text></ref><ref id="CR54"><text><SENT sid="314" pm="."><plain>54.EngelhardtJFSteelGValleDTranscriptional analysis of the human <z:uniprot sup="inside" fb="0" ids="C3P3K3,C3LBX0,Q81TV3,C1EL61,B9ITF9,Q81GP2,Q9K5Z2,P38021,Q7WP51,Q7W1E4,Q7VSA0,Q89RB7,C0ZBR4,Q92413,C4L2E7,C5D6R2,Q6CWC1,B9EAM9,Q8EP32,Q4XWV5,Q6LFH8,Q07805,Q7RT90,B9DIU0,Q5HQK4,Q8CT82,P31893,P07991,Q5JEW1">ornithine aminotransferase</z:uniprot> promoterJ Biol Chem199126675281845993 </plain></SENT>
</text></ref><ref id="CR55"><text><SENT sid="315" pm="."><plain>55.KimuraTChristoffelsVMChowdhurySIwaseKMatsuzakiHMoriMHypoglycemia-associated hyperammonemia caused by impaired expression of ornithine cycle enzyme genes in <z:uniprot sup="inside" fb="0" ids="O02754,P49715,P53566,P05554">C/EBPalpha</z:uniprot> knockout miceJ Biol Chem1998273275051010.1074/jbc.273.42.275059765281 </plain></SENT>
</text></ref><ref id="CR56"><text><SENT sid="316" pm="."><plain>56.SchutzYProtein turnover, ureagenesis and gluconeogenesis. </plain></SENT>
<SENT sid="317" pm="."><plain>International journal for vitamin and nutrition research. </plain></SENT>
<SENT sid="318" pm="."><plain>Internationale Zeitschrift fur Vitamin- und ErnahrungsforschungJ Int Vitam Nutr201181101710.1024/0300-9831/a000064 </plain></SENT>
</text></ref><ref id="CR57"><text><SENT sid="319" pm="."><plain>57.MillwardCAHeaneyJDSinasacDSChuECBedermanIRGilgeDAMice with a deletion in the gene for <z:uniprot sup="inside" fb="0" ids="O02755,Q05826,P17676,P28033,P21272">CCAAT/enhancer-binding protein beta</z:uniprot> are protected against diet-induced obesityDiabetes200756161710.2337/db06-031017192478 </plain></SENT>
</text></ref><ref id="CR58"><text><SENT sid="320" pm="."><plain>58.MaDLinJDCircadian regulation of autophagy rhythm through transcription factor C/EBPbetaAutophagy20128124510.4161/auto.8.1.1808122082962 </plain></SENT>
</text></ref><ref id="CR59"><text><SENT sid="321" pm="."><plain>59.KingDPZhaoYSangoramAMWilsbacherLDTanakaMAntochMPPositional cloning of the mouse circadian clock geneCell1997896415310.1016/S0092-8674(00)80245-79160755 </plain></SENT>
</text></ref><ref id="CR60"><text><SENT sid="322" pm="."><plain>60.AntochMPSongEJChangAMVitaternaMHZhaoYWilsbacherLDFunctional identification of the mouse circadian Clock gene by transgenic BAC rescueCell1997896556710.1016/S0092-8674(00)80246-99160756 </plain></SENT>
</text></ref><ref id="CR61"><text><SENT sid="323" pm="."><plain>61.SaigusaDShibuyaMJinnoDYamakoshiHIwabuchiYYokosukaAHigh-performance liquid chromatography with photodiode array detection for determination of nobiletin content in the brain and serum of mice administrated the natural compoundAnal Bioanal Chem201140036354110.1007/s00216-011-5031-221559759 </plain></SENT>
</text></ref><ref id="CR62"><text><SENT sid="324" pm="."><plain>62.MantheyJACesarTBJacksonEMertens-TalcottSPharmacokinetic study of nobiletin and tangeretin in rat serum by high-performance liquid chromatography-electrospray ionization-mass spectrometryJ Agric Food Chem2011591455110.1021/jf103322421133365 </plain></SENT>
</text></ref><ref id="CR63"><text><SENT sid="325" pm="."><plain>63.EvansMSharmaPGuthrieNBioavailability of citrus polymethoxylated flavones and their biological role in metabolic syndrome and hyperlipidemiaed. </plain></SENT>
<SENT sid="326" pm="."><plain>InTech2012119 </plain></SENT>
</text></ref><ref id="CR64"><text><SENT sid="327" pm="."><plain>64.ArangoDMorohashiKYilmazAKuramochiKPariharABrahimajBMolecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targetsProc Natl Acad Sci U S A2013110E21536210.1073/pnas.130372611023697369 </plain></SENT>
</text></ref><ref id="CR65"><text><SENT sid="328" pm="."><plain>65.ZhouCHWuXHWuYQNobiletin, a dietary phytochemical, inhibits vascular smooth muscle cells proliferation via calcium-mediated c-Jun N-terminal kinases pathwayEur J Pharmacol2009615556010.1016/j.ejphar.2009.05.02519486902 </plain></SENT>
</text></ref><ref id="CR66"><text><SENT sid="329" pm="."><plain>66.LeeYCChengTHLeeJSChenJHLiaoYCFongYNobiletin, a citrus flavonoid, suppresses invasion and migration involving <z:uniprot sup="inside" fb="0" ids="Q00944,Q05397">FAK</z:uniprot>/<z:uniprot sup="inside" fb="0" ids="P54673,P42347,P54674,P42348,P54675,P54676">PI3K</z:uniprot>/<z:uniprot sup="inside" fb="10" ids="Q8INB9,P31750">Akt</z:uniprot> and small GTPase signals in human gastric adenocarcinoma <z:uniprot sup="inside" fb="2" ids="A3N062,B3GXD3,B0BNY0,A6VMR4,A0KLC8,A4SNY1,Q5E7B6,B5FAS8,C1DJG1,O66143,P59099,P0A6C7,P0A6C6,P0A6C5,C5BH95,A4WDZ5,B7LW98,Q7VLN8,Q65UJ9,O33289,Q9JW21,Q9JXU9,Q9CMJ6,Q6D8H5,C6DAG1,Q7N8S4,Q6LMZ6,B4F2F5,A6VDY0,B7V594,Q02EG0,P22567,Q4K434,C3K3V3,A4XP61,Q3K4Z8,B0KP70,P0A0Z9,P0A100,Q88AR2,P61919,Q4ZZU5,Q8XZZ5,A9MS91,Q8Z421,Q8ZMB8,A8GIG8,P59292,P59293,Q9KPQ0,Q87M87,B7VJZ6,P59294,Q7MIA6,A1JPB6,A7FFE9,Q1CAR0,B2JZ56,Q8ZH86,A9R2Q4,Q1CFC4,Q667G9,B1JQD9,P70490,A6RBX7,Q75A07,A1C6J2,B0XSH8,B8NG97,Q4X122,A2QGF0,Q2UES9,Q0CY06,A6SG85,Q59MB6,B9W7S3,Q6FS75,Q1DNE1,A8N2M6,P0CM19,P0CM18,Q6BZ43,Q5B0R3,Q6CRT7,B0CR45,A5DWN5,A4RKF7,A1DH62,Q1K8F6,B6H6F3,Q0U6Q5,A5DA88,Q595W7,A3GG03,B2B2C5,B2WME0,B6JWC1,O94330,A7F8R0,B6QS64,B8M3T8,A7TQL5,Q6CEE1,B3LQ40,A6ZPQ2,P40360">AGS</z:uniprot> cellsMol Cell Biochem20113471031510.1007/s11010-010-0618-z20963626 </plain></SENT>
</text></ref><ref id="CR67"><text><SENT sid="330" pm="."><plain>67.WhitmanSCKurowskaEMMantheyJADaughertyANobiletin, a citrus flavonoid isolated from tangerines, selectively inhibits class A scavenger receptor-mediated metabolism of acetylated LDL by mouse macrophagesAtherosclerosis2005178253210.1016/j.atherosclerosis.2004.07.03415585197 </plain></SENT>
</text></ref><ref id="CR68"><text><SENT sid="331" pm="."><plain>68.MinamiYKasukawaTKakazuYIigoMSugimotoMIkedaSMeasurement of internal body time by blood metabolomicsProc Natl Acad Sci U S A20091069890510.1073/pnas.090061710619487679 </plain></SENT>
</text></ref><ref id="CR69"><text><SENT sid="332" pm="."><plain>69.TuBPMohlerRELiuJCDombekKMYoungETSynovecRECyclic changes in metabolic state during the life of a yeast cellProc Natl Acad Sci U S A2007104168869110.1073/pnas.070836510417940006 </plain></SENT>
</text></ref><ref id="CR70"><text><SENT sid="333" pm="."><plain>70.ChenZMcKnightSLA conserved DNA damage response pathway responsible for coupling the cell division cycle to the circadian and metabolic cyclesCell Cycle2007629061210.4161/cc.6.23.504118000400 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
